In our forthcoming work, we intend to elucidate the regulatory role of BHLHE40 in T cells, which is thought to promote malignant progression of pancreatic cancer by suppressing anti-neoplastic inflammatory responses. Here, BHLHE40 is linked to familial pancreatic carcinoma.